USA's HHS launches Office of Recovery Act Coordination
The US Department of Health and Human Services has announced the creation of the Office of Recovery Act Coordination. This will help ensure the timely, organized and transparent distribution of an estimated $137.0 billion in Recovery Act Funds managed by the Department of Health and Human Services.
"HHS is committed to moving quickly and carefully to distribute Recovery Act funds in an open and transparent manner," said agency spokeswoman Jenny Backus. "We have already worked to put more than $3.0 billion in Recovery Act funds into states and the new Office of Recovery Act Coordination will enhance and streamline our efforts to get critical resources and potential new job opportunities to the American people during tough times," she added.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze